Roche’s Genentech unit signed a trio of deals this ... competition for its ‘big three’ antibodies – Rituxan, Herceptin and Avastin – which together accounted for more than a third ...

The FDA has approved Amgen and Allergan’s biosimilar of Roche’s Herceptin, just in time for the breast cancer blockbuster’s patent expiry. Herceptin’s main US patent expires this month ...

Story June 11 - Genentech: The Roche subsidiary is letting go of 143 employees at a South San Francisco site, according to a California WARN notice filed for May 29. The workforce reduction will ...